Trials / Completed
CompletedNCT00356603
Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan
Imigran STATdose - Japan Clinical Experience Study for Self-injection
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study will be conducted to collect cases treated by self-injection of sumatriptan 3mg kit product for the treatment of migraine or cluster headache attacks in clinical settings, to demonstrate the efficacy, and to examine patient acceptability (simplicity and usefulness) and rate of successful self-injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sumatriptan Succinate | Sumatriptan Succinate |
Timeline
- Start date
- 2006-06-20
- Primary completion
- 2006-08-07
- Completion
- 2006-08-07
- First posted
- 2006-07-26
- Last updated
- 2018-09-04
- Results posted
- 2017-11-20
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00356603. Inclusion in this directory is not an endorsement.